Status:
COMPLETED
CMR Repeatability in STEMI
Lead Sponsor:
University of Bristol
Conditions:
STEMI
Eligibility:
FEMALE
18-85 years
Brief Summary
The investigators propose to conduct a study to measure the reproducibility of CMR parameters that have been used to predict outcome following PPCI: infarct size, left ventricular volumes, myocardial ...
Eligibility Criteria
Inclusion
- Participant may enter study if ALL of the following apply
- ST segment myocardial infarction as defined by ECG (by 2 contiguous limb leads with \>1 mm ST-segment elevation, or \>2 mm ST-segment elevation in contiguous precordial leads, or new LBBB) and \> 20 minutes of cardiac chest pain
- Written informed consent
Exclusion
- Participant may not enter study if ANY of the following apply
- Contraindication to MRI (implanted pacemaker/ defibrillator, ferromagnetic metal implant/ injury, claustrophobia, obesity/ too large for CMR scanner)
- Known allergy to gadolinium
- Chronic atrial fibrillation
- Renal impairment with eGFR \<30
- Cardiogenic shock
- Patients with special communication needs
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01468662
Start Date
November 1 2011
Last Update
October 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bristol Heart Institute
Bristol, United Kingdom, BS2 8HW